Status:
TERMINATED
Group Metacognitive Therapy for Anxiety and Depression in Cancer Survivors
Lead Sponsor:
University of Liverpool
Collaborating Sponsors:
University of Manchester
Liverpool University Hospitals NHS Foundation Trust
Conditions:
Cancer
Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to test the potential of group metacognitive therapy in alleviating emotional distress in cancer survivors. The investigators aim to find out if a group based approach is acceptable to...
Detailed Description
Survival rates in cancer continue to improve, with over 2 million adult cancer survivors in the United Kingdom, projected to increase to 4 million by 2030. Around 25% of these survivors require treatm...
Eligibility Criteria
Inclusion
- Cancer diagnosis at least 6 months previously
- A score of at least 15 on the Total scale score of the Hospital Anxiety and Depression Scale (HADS)
- Sufficient understanding of English to consent and engage in therapy
- Stable on, or free from, psychotropic medication
- Minimum of 18 years old
Exclusion
- History of psychotic disorder, learning disability, or organic mental disorder
- Risk of self-harm or suicide warranting immediate intervention
- In palliative phase of treatment
- Being considered for risk-reducing or reconstructive surgery within 1 year
- Concurrent psychological intervention for emotional distress
- Cognitive impairment precluding informed consent or participation
- Undergoing acute medical treatment (e.g. chemotherapy, radiotherapy)
- Current drug/alcohol abuse
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2018
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03424512
Start Date
April 1 2018
End Date
December 10 2018
Last Update
August 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Liverpool and Broadgreen NHS Trust
Liverpool, Merseyside, United Kingdom, L78XP